157 related articles for article (PubMed ID: 36047198)
1. Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.
Shimomura T; Sekiguchi M; Honda R; Yamazaki M; Yokoyama M; Uchiyama S
Biol Pharm Bull; 2022; 45(9):1300-1305. PubMed ID: 36047198
[TBL] [Abstract][Full Text] [Related]
2. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions.
Wei Y; Qi W; Maglalang E; Pelegri-O'Day EM; Luong M; Razinkov V; Sloey C
Mol Pharm; 2023 Dec; 20(12):6420-6428. PubMed ID: 37906640
[TBL] [Abstract][Full Text] [Related]
3. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.
Tomar DS; Li L; Broulidakis MP; Luksha NG; Burns CT; Singh SK; Kumar S
MAbs; 2017 Apr; 9(3):476-489. PubMed ID: 28125318
[TBL] [Abstract][Full Text] [Related]
4. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
[TBL] [Abstract][Full Text] [Related]
5. Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks.
Schmitt J; Razvi A; Grapentin C
MAbs; 2023; 15(1):2169440. PubMed ID: 36705325
[TBL] [Abstract][Full Text] [Related]
6. Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter.
Connolly BD; Petry C; Yadav S; Demeule B; Ciaccio N; Moore JM; Shire SJ; Gokarn YR
Biophys J; 2012 Jul; 103(1):69-78. PubMed ID: 22828333
[TBL] [Abstract][Full Text] [Related]
7. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
Buck PM; Chaudhri A; Kumar S; Singh SK
Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
[TBL] [Abstract][Full Text] [Related]
8. In Silico Prediction of Diffusion Interaction Parameter (k
Tomar DS; Singh SK; Li L; Broulidakis MP; Kumar S
Pharm Res; 2018 Aug; 35(10):193. PubMed ID: 30128780
[TBL] [Abstract][Full Text] [Related]
9. Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.
Li L; Kumar S; Buck PM; Burns C; Lavoie J; Singh SK; Warne NW; Nichols P; Luksha N; Boardman D
Pharm Res; 2014 Nov; 31(11):3161-78. PubMed ID: 24906598
[TBL] [Abstract][Full Text] [Related]
10. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
11. Micro- and macro-viscosity relations in high concentration antibody solutions.
Shah M; Corbett D; Lanzaro A; Roche A; Sibanda N; Davis P; Uddin S; van der Walle CF; Curtis R; Pluen A
Eur J Pharm Biopharm; 2020 Aug; 153():211-221. PubMed ID: 32574706
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
13. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.
Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM
Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965
[TBL] [Abstract][Full Text] [Related]
14. Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions.
Mosca I; Pounot K; Beck C; Colin L; Matsarskaia O; Grapentin C; Seydel T; Schreiber F
Mol Pharm; 2023 Sep; 20(9):4698-4713. PubMed ID: 37549226
[TBL] [Abstract][Full Text] [Related]
15. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
[TBL] [Abstract][Full Text] [Related]
16. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
[TBL] [Abstract][Full Text] [Related]
17. Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG
Dai J; Izadi S; Zarzar J; Wu P; Oh A; Carter PJ
MAbs; 2024; 16(1):2304282. PubMed ID: 38269489
[TBL] [Abstract][Full Text] [Related]
18. A single molecular descriptor to predict solution behavior of therapeutic antibodies.
Kingsbury JS; Saini A; Auclair SM; Fu L; Lantz MM; Halloran KT; Calero-Rubio C; Schwenger W; Airiau CY; Zhang J; Gokarn YR
Sci Adv; 2020 Aug; 6(32):eabb0372. PubMed ID: 32923611
[TBL] [Abstract][Full Text] [Related]
19. Models for Antibody Behavior in Hydrophobic Interaction Chromatography and in Self-Association.
Hebditch M; Roche A; Curtis RA; Warwicker J
J Pharm Sci; 2019 Apr; 108(4):1434-1441. PubMed ID: 30476509
[TBL] [Abstract][Full Text] [Related]
20. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
